Euromedis Groupe reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 54.18 million compared to EUR 111.9 million a year ago. Revenue was EUR 61.35 million compared to EUR 117.61 million a year ago.

Net loss was EUR 5.93 million compared to net income of EUR 2.26 million a year ago. Basic loss per share from continuing operations was EUR 1.97 compared to basic earnings per share from continuing operations of EUR 0.75 a year ago.